Event news for the 2nd T-Cell Engager for Autoimmune Disease Summit

Click to explore all of our content related to the 2026 event.

Speaker Interview with Kali Therapeutics

Speaker Interview: Min Bao from Kali Therapeutics

2nd T-Cell Engager for Autoimmune Disease Summit: Hear From an Expert Speaker Taking the Stage at this Years Summit
Speaker Interview withGV20 Therapeutics

Speaker Interview: Xingfeng Bao from GV20 Therapeutics

We caught up with one of the researchers joining the 2nd T-Cell Engager for Autoimmune Disease Summit to learn more about their work.

Networking at 2nd T-Cell Engager for Autoimmune Disease Summit

Autoimmune TCE Development Insights

Learn how developers are addressing translation, safety, biomarkers, and clinical execution challenges.

Panel at 2nd T-Cell Engager for Autoimmune Disease Summit

Autoimmune TCE Summit Returns

Discover what's new for 2026, including expert speakers and next-generation autoimmune TCE strategies.

Audience at 2nd T-Cell Engager for Autoimmune Disease Summit

A Defining Moment for Autoimmune TCEs

Explore the trends, challenges, and innovators driving the next generation of autoimmune T-cell engagers.

Explore the Agenda - About Event - T-Cell Engager for Autoimmune Disease Summit

Explore the Agenda

Discover the latest strategies to engineer safer, more effective autoimmune T-cell engagers through expert-led case studies, clinical data presentations, panel discussions, and interactive workshops.

Partner with us - T-Cell Engager for Autoimmune Disease Summit

Partner With Us

Showcase your technologies, platforms, and services to biotech and pharma leaders actively developing next-generation autoimmune T-cell engagers and seeking partners to accelerate discovery, translation, and clinical success.

Join Biopharma Experts - T-Cell Engager for Autoimmune Disease Summit

Join Autoimmune T-Cell Engager Leaders

Connect with discovery, translational, preclinical, and clinical experts driving the next generation of autoimmune T-cell engagers through innovation in target discovery, molecule engineering, and clinical development.